ST段抬高心肌梗死患者择期经皮冠脉介入治疗预后的危险因素分析  

Risk Factors Analysis on Prognosis of ST Segment Elevation Myocardial Infarction Patients Carrying out Selective Operation of Percutaneous Coronary Intervention

作　　者：沈正[1] 李屏[1] 

机构地区：[1]贵州医科大学附属医院心血管内科,550004

出　　处：《中国卫生统计》2016年第5期782-784,共3页Chinese Journal of Health Statistics

基　　金：贵阳市科技计划项目(201310324)

摘　　要：目的探讨ST段抬高心肌梗死(STEMI)患者实施择期经皮冠脉介入(PCI)治疗预后死亡的相关危险因素,为改善预后提供依据。方法采用病例对照的方法,将确诊的162例STEMI患者实施PCI治疗后1年内是否死亡分为存活组和死亡组,采用单因素和多因素的方法来筛选其死亡的相关危险因素。结果 STEMI患者实施PCI手术后1年内死亡率高达39.5%(64/162);多因素logistic回归结果显示年龄(OR=3.114)、糖尿病(OR=3.892)、心功能分级(OR=2.234)、HbA1c(OR=4.158)、症状开始至灌注时长(OR=4.027)、未联合使用相关药物(OR=2.617)等因素均为其死亡的危险因素。结论 STEMI患者实施择期PCI手术后1年内具有较高的死亡率,影响其死亡的独立危险因素包括高龄、合并基础疾病、心功能差、Hb A1c水平较高、症状开始至灌注时长、术后未联合使用相关药物。Objective To explore the risk factors of prognosis death of ST segment elevation myocardial infarction （STEMI） patients carrying out selective operation of percutaneous coronary intervention（PCI） ,provide basis for early improving prognosis. Methods With Case-control study method, 162 cases of STEMI patients were divided into death group and survival group according to the prognosis of one year, the risk factors of prognosis death were screened by single factor and multiple factors methods. Results The death rate of one year about STEMI patients carrying out PCI operation was 39.5% （64/162）. Multiple factors logistic Regression result showed that these factors such as age（ OR = 3.114）, diabetes mellitus （OR = 3. 892 ）, cardiac functional grading （ OR = 2. 234 ）, HblA1c level OR = 4. 158 ）, length from symptom to perfusion （ OR = 4. 027 ） and without combination of correlated drugs （ OR = 2. 617 ） were the risk factors of prognosis death. Conclusion These STEMI patients carrying out selective operation of PCI exist a high death rate of prognosis. The independent risk factors of prognosis death include in high age, complication of underlying disease, bad heart function, high level of HbA1c, length from symptom to perfection and without combination use of correlated drugs.

关 键 词：ST段抬高心肌梗死 经皮冠脉介入治疗 预后 死亡 危险因素 

分 类 号：R542.22[医药卫生—心血管疾病]